2 terminated, 1 completed, 1 recruiting. 2 Phase 2, 1 Early Phase 1, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Terminated 1 |
| Early Phase 1 | 1 | Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow John O. Prior: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| [68Ga]Ga-FAPI-46 in Staging of Head and Neck Carcinomas [68Ga]Ga-FAPI-46 PET/CT - Head and Neck Squamous Cell Carcinoma HNSCC | Phase 2 | Recruiting | John O. Prior | 20 | 2025-06-23 | 2026-05-06 |
| Theranostics in Soft Tissue Sarcoma Using a Vascular Disruption Approach Ga-68-PSMA-11 PET/CT, Lu-177-ITG-PSMA-1 - Soft Tissue Sarcoma | Phase 1 | Completed | John O. Prior | 14 | 2023-02-08 | 2024-06-18 |
| [68Ga]Ga-PentixaFor PET/CT in Acute Myocardial Inflammation [68Ga]Ga-PentixaFor PET/CT - Acute Cellular Graft Rejection, Cardiac Sarcoidosis | Phase 2 | Terminated | John O. Prior | 25 | 2023-01-17 | 2026-10-13 |
| Feasibility of IV Tc-99m-tilmanocept for Imaging of M2-like TAMs in Metastatic Melanoma Tc-99m tilmanocept - Melanoma | Early Phase 1 | Terminated | John O. Prior | 5 | 2021-02-01 | 2023-12-13 |
Melanoma (1) · Sarcoma (1) · Squamous Cell Carcinoma of Head and Neck (1)
technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran (1)
Switzerland (4)
John O Prior, MD, PhD (1) · John O Prior, PhD MD (1) · Niklaus Schaefer, MD (1) · Niklaus Schaefer, Prof. (1)